capstantx.comHealthcare / Healthcare providers & servicesFounded: 2021Funding to Date: $340MM
Capstan Therapeutics is a biotechnology company that strives to develop new treatments for a variety of diseases using in vivo cell engineering, which is a method that aims to modify cells inside the body. Their core technology involves targeted lipid nanoparticles (tLNPs) seeking to manipulate cells for therapeutic purposes. Areas of interest for the company include oncology, fibrosis, inflammatory disease, and blood disorders. Capstan Therapeutics was founded in 2021 and is headquartered in San Diego, California.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Capstan Therapeutics.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.